NantHealth, Inc. (NHIQ)
OTCMKTS: NHIQ · Delayed Price · USD
0.600
-0.297 (-33.11%)
Jun 17, 2024, 9:54 AM EDT - Market closed
NantHealth Market Cap
NantHealth has a market cap or net worth of $16.48 million as of July 2, 2024. Its market cap has decreased by -75.83% in one year.
Market Cap
16.48M
Enterprise Value
285.04M
1-Year Change
-75.83%
Ranking
n/a
Category
Stock Price
$0.60
Market Cap Chart
Since June 2, 2016, NantHealth's market cap has decreased from $2.19B to $16.48M, a decrease of -99.25%. That is a compound annual growth rate of -50.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2023 | 10.40M | -62.99% |
| Dec 30, 2022 | 28.10M | -76.93% |
| Dec 31, 2021 | 121.80M | -66.09% |
| Dec 31, 2020 | 359.20M | 215.36% |
| Dec 31, 2019 | 113.90M | 91.11% |
| Dec 31, 2018 | 59.60M | -81.96% |
| Dec 29, 2017 | 330.40M | -72.58% |
| Dec 30, 2016 | 1.21B | -44.99% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 860.48B |
| Novo Nordisk | 629.27B |
| UnitedHealth Group | 468.72B |
| Johnson & Johnson | 351.76B |
| Merck & Co. | 313.56B |
| AbbVie | 302.88B |
| AstraZeneca | 241.81B |
| Thermo Fisher | 211.09B |